Identification of an anti-inflammatory protein fromFaecalibacterium prausnitzii, a commensal bacterium deficient in Crohn’s disease-Reference-Cited by-同舟云学术

Identification of an anti-inflammatory protein fromFaecalibacterium prausnitzii, a commensal bacterium deficient in Crohn’s disease

Published:2015-06-04 Issue:3 Volume:65 Page:415-425
ISSN:0017-5749
Container-title:Gut
language:en
Short-container-title:Gut

Author:

Quévrain E,Maubert M A,Michon C,Chain F,Marquant R,Tailhades J,Miquel S,Carlier L,Bermúdez-Humarán L G,Pigneur B,Lequin O,Kharrat P,Thomas G,Rainteau D,Aubry C,Breyner N,Afonso C,Lavielle S,Grill J-P,Chassaing G,Chatel J M,Trugnan G,Xavier R,Langella P,Sokol H,Seksik P

Publisher

BMJ

Subject

Gastroenterology

Reference50 articles.

1. Alterations of the mucosal immune system in inflammatory bowel disease;MacDermott;J Gastroenterol,1996

2. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease;Hugot;Nature,2001

3. Regulatory T cells: peace keepers in the gut;Allez;Inflamm Bowel Dis,2004

4. Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics;Sartor;Gastroenterology,2004

5. Genetics and pathogenesis of inflammatory bowel disease;Khor;Nature,2011

Cited by 604 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the relationship between Faecalibacterium duncaniae and Escherichia coli in inflammatory bowel disease (IBD): Insights and implications;Computational and Structural Biotechnology Journal;2024-12

2. Genetically engineered bacteria as inflammatory bowel disease therapeutics;Engineering Microbiology;2024-12

3. Description of Faecalibacterium wellingii sp. nov. and two Faecalibacterium taiwanense strains, aiding to the reclassification of Faecalibacterium species;Anaerobe;2024-10

4. Alterations of the microbiome across body sites in systemic lupus erythematosus: A systematic review and meta-analysis;Lupus;2024-09-11

5. The complex link between the gut microbiome and obesity-associated metabolic disorders: Mechanisms and therapeutic opportunities;Heliyon;2024-09